Replies to post #73238 on Anavex Life Sciences Corp (AVXL)

[lt2211]

Realistically It amounts to the same thing, no charges in the investigation. It's over. Now, this relates only to the info in their prior 2015 10-K, where they told everyone the SEC had opened a dialog with the company. Not any peripheral investigations that may be under way on manipulation etc. At least that's the way I read it. This has been a big concern to many investors.

The SEC didn't really say the investigation was over, just that they wouldn't be bringing enforcement charges

[scottsmith]

The stock price was most certainly manipulated up last fall. It may have been manipulated down.

[apostrophe]

re: '...I'm hoping they are still investigating, including the recent manipulation ..."

Kind of hoping too. Wishful thinking it seems. Now feeling a bit irked again even though it's over. It may be uncharitable to say so, but sometimes it seems like the SEC isn't very bright.

I also got thinking about how easily the FDA was manipulated for nefarious purposes.

https://www.statnews.com/2015/09/26/biotech-exec-martin-shkreli-has-history-of-tough-tactics/

"Four years ago, Shkreli asked the Food and Drug Administration to reject a new type of cancer diagnostic from a small drug maker called Navidea Biopharmaceuticals. He simultaneously — and very publicly — bet against the company’s stock. He had earlier tried a similar tactic against another company, MannKind Corp., that was developing an inhalable insulin.

The moves caused Navidea’s value to plummet at the time, threatening to hurt the company’s ability to prepare for the launch of the product.

Ultimately, the FDA approved the diagnostic, which some physicians now see as a valuable medical tool — and one that patients might not have had access to if Shkreli had succeeded.

“It was like a frivolous lawsuit that bottlenecks the system and threatens progress,” said Dr. Anne Wallace, a breast cancer surgeon at the University of California, San Diego, who ran clinical trials for Navidea’s diagnostic. “This sort of tactic can ruin science.” "

So who started this, baiting the SEC? Did Anavex get to face their accusors? Or was some person in a Shkreli or otherwise diabolical mindset simply able make an anonymous phone call or something, screeching wild accusations about Anavex? Seems like the SEC was manipulated into investigating the victim instead of the perpetrator. Besides compelling the SEC to waste resources on a wild goose chase, as a result of false accusation, news of the secretive investigation along with rumor mongering of presumed guilt, serious damage was inflicted on the company and its shareholders. No coincidence that the scheme facilitated the profits of short sellers.

There are penalties for making a fraudulant complaint or false report to the police. Wonder if anything like that exists for the SEC.

[TomP1]

I read it as the SEC saying they have investigated AVXL management and found no violations.